Literature DB >> 22682795

Adult primary immune deficiency: what are we missing?

Bharat T Srinivasa1, Reza Alizadehfar, Martin Desrosiers, Joseph Shuster, Nitika Pant Pai, Christos M Tsoukas.   

Abstract

BACKGROUND: More than 200 primary immune deficiencies have been described. In adults, their identification can be difficult. The lack of timely referrals, diagnostic facilities, and available expertise often delay appropriate treatment. Because an increasing number of adults are now diagnosed with immune deficiencies, there is a need to better understand the immune deficits in this age group. The study objective was to analyze the diagnostic spectrum of adults with primary immune deficiency and to determine the presumptive diagnostic accuracy of the referring physicians.
METHODS: We conducted a retrospective chart review over a 10-year period of all individuals referred to a dedicated center for adults with primary immune deficiency. Suspected cases were confirmed using standard clinical criteria and state of the art immune assays.
RESULTS: Of the 381 individuals studied, 244 were diagnosed as immune deficient. Of these, 210 had primary immune deficiency classified as novel, defined, and undefined. Forty-three patients had a prior diagnosis and were referred for follow-up care, and 201 patients were newly diagnosed. Most patients had common variable immune deficiency. Despite an apparent high index of suspicion in initiating the referrals, only one third of these patients had a prior quantitative assessment of serum immunoglobulins.
CONCLUSIONS: In this first known analysis of a large cohort of adults with suspected immune deficiency using established diagnostic criteria, we confirmed the diagnosis in two thirds of all patients. Our findings highlight the wide spectrum of primary immune deficiency states seen in adult medical practices and the need for increased awareness of their existence.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22682795     DOI: 10.1016/j.amjmed.2012.02.015

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  14 in total

1.  Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry.

Authors:  Asghar Aghamohammadi; Payam Mohammadinejad; Hassan Abolhassani; Babak Mirminachi; Masoud Movahedi; Mohammad Gharagozlou; Nima Parvaneh; Vaheid Zeiaee; Bahram Mirsaeed-Ghazi; Zahra Chavoushzadeh; Alireza Mahdaviani; Mahboubeh Mansouri; Sedigheh Yousefzadegan; Bahareh Sharifi; Fariborz Zandieh; Ehsan Hedayat; Ali Nadjafi; Roya Sherkat; Behzad Shakerian; Mahnaz Sadeghi-Shabestari; Reza Farid Hosseini; Farahzad Jabbari-Azad; Hamid Ahanchian; Fatemeh Behmanesh; Mohammadreza Zandkarimi; Afshin Shirkani; Taher Cheraghi; Abbas Fayezi; Iraj Mohammadzadeh; Reza Amin; Soheila Aleyasin; Mojgan Moghtaderi; Javad Ghaffari; Saba Arshi; Naser Javahertrash; Mohammad Nabavi; Mohammad Hassan Bemanian; Alireza Shafiei; Najmedin Kalantari; Akefeh Ahmadiafshar; Hossein Ali Khazaei; Lida Atarod; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05       Impact factor: 8.317

2.  Interest of immunodeficiency screening in adult after admission in medical intensive care unit for severe infection, a retrospective and a prospective study: the Intensive Care Unit and Primary and Secondary Immunodeficiency (ICUSPID) study.

Authors:  Aurélie Baldolli; Nicolas Martin Silva; Amélie Seguin; Gwenola Maigne; Audrey Sultan; Samuel Deshayes; Damien Du Cheyron; Aurélie Joret; Nizar Mahlaoui; Boris Bienvenu
Journal:  Infection       Date:  2018-09-07       Impact factor: 3.553

Review 3.  Humoral Primary Immunodeficiencies in Chronic Rhinosinusitis.

Authors:  Smriti Nayan; Reza Alizadehfar; Martin Desrosiers
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

4.  Modeling strategy to identify patients with primary immunodeficiency utilizing risk management and outcome measurement.

Authors:  Vicki Modell; Jessica Quinn; Grant Ginsberg; Ron Gladue; Jordan Orange; Fred Modell
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

5.  Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network.

Authors:  Vicki Modell; Jessica Quinn; Jordan Orange; Luigi D Notarangelo; Fred Modell
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

6.  Modulation of the Interleukin-21 Pathway with Interleukin-4 Distinguishes Common Variable Immunodeficiency Patients with More Non-infectious Clinical Complications.

Authors:  Marylin Desjardins; Marianne Béland; Marieme Dembele; Duncan Lejtenyi; Jean-Phillipe Drolet; Martine Lemire; Christos Tsoukas; Moshe Ben-Shoshan; Francisco J D Noya; Reza Alizadehfar; Christine T McCusker; Bruce D Mazer
Journal:  J Clin Immunol       Date:  2017-11-04       Impact factor: 8.317

7.  Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery.

Authors:  Vicki Modell; Megan Knaus; Fred Modell; Chaim Roifman; Jordan Orange; Luigi D Notarangelo
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

8.  Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes.

Authors:  Vicki Modell; Jordan S Orange; Jessica Quinn; Fred Modell
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

9.  Fertility, pregnancies and outcomes reported by females with common variable immune deficiency and hypogammaglobulinemia: results from an internet-based survey.

Authors:  Adi V Gundlapalli; Christopher Scalchunes; Marcia Boyle; Harry R Hill
Journal:  J Clin Immunol       Date:  2015-01-09       Impact factor: 8.317

10.  A Novel Targeted Screening Tool for Hypogammaglobulinemia: Measurement of Serum Immunoglobulin (IgG, IgM, IgA) Levels from Dried Blood Spots (Ig-DBS Assay).

Authors:  Leman Yel; Christopher J Rabbat; Charlotte Cunningham-Rundles; Jordan S Orange; Troy R Torgerson; James W Verbsky; Yeong Wang; Maoyong Fu; Terry S Robins; Marc S Edwards; Jesper Nymann-Andersen
Journal:  J Clin Immunol       Date:  2015-08-16       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.